Janet Fisher to Melanoma, Experimental
This is a "connection" page, showing publications Janet Fisher has written about Melanoma, Experimental.
Connection Strength
0.267
-
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. J Immunother Cancer. 2020 04; 8(1).
Score: 0.161
-
Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Res. 2014 May; 27(3):495-501.
Score: 0.106